Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Feb;46(2):285-7.
doi: 10.1016/j.yjmcc.2008.10.026. Epub 2008 Nov 12.

Reduced SERCA2a converts sub-lethal myocardial injury to infarction and affects postischemic functional recovery

Affiliations

Reduced SERCA2a converts sub-lethal myocardial injury to infarction and affects postischemic functional recovery

M A Hassan Talukder et al. J Mol Cell Cardiol. 2009 Feb.

Abstract

The goal of the present study was to assess how reduced SERCA2a expression affects in vivo myocardial ischemia/reperfusion (I/R) injury. We specifically wanted to determine to what extent hearts with reduced SERCA2a levels are susceptible to in vivo I/R injury. Therefore, we examined the effects of different ischemic periods on post-ischemic myocardial injury in wild-type (WT) and SERCA2a heterozygous knockout (SERCA2a(+/-)) mice expressing lower levels of SERCA2a pump in vivo. Following 20-min ischemia and 48-hour reperfusion, SERCA2a(+/-) mice developed significant myocardial infarction (MI) compared to negligible infarction in WT mice (14+/-3% vs. 3+/-1%, P<0.01); whereas following 30-min ischemia, the infarction was significantly larger in SERCA2a(+/-) mice compared to WT mice (49+/-5% vs. 37+/-3%, P<0.05). Further, echocardiographic analysis revealed worsened postischemic contractile function in SERCA2a(+/-) mice compared to WT mice. Thus, these findings demonstrate that maintaining optimal SERCA2a function is critical for myocardial protection from I/R injury and postischemic functional recovery.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Myocardial infarction and function in hearts subjected to 20-min LAD ligation and 48-hour reperfusion. (A) Immunoblots and bar graphs for SERCA2a protein levels in WT and SERCA2a+/− hearts, calsequestrin as internal control (N = 3/group). (B) Representative sections of hearts stained with phthalo blue and 2,3,5-triphenyltetrazolium chloride after I/R. (C) Percentage of area at risk (AAR) over left ventricle (LV) and infarct area (IA) over AAR. All values are means ± SEM. N =5–6/group; *P<0.05 vs. WT; **P<0.01 vs. WT.
Fig. 2
Fig. 2
Myocardial function and infarction in hearts subjected to 30-min LAD ligation and 48-hour reperfusion. (A) FS (%) before (pre-MI) and after MI (post-MI). (B, C) Please see Fig. 1 for description. N =5–7/group.P<0.05 vs. Pre-MI; ††P<0.01 vs. Pre-MI; *P<0.05 vs. WT.

Similar articles

Cited by

References

    1. Bolli R, Becker L, Gross G, Mentzer R, Jr, Balshaw D, Lathrop DA. Myocardial protection at a crossroads: the need for translation into clinical therapy. Circ Res. 2004;95:125–34. - PubMed
    1. Smith G. Matters of the heart: the physiology of cardiac function and failure. Exp Physiol. 2007;92:973–86. - PubMed
    1. Burns RJ, Gibbons RJ, Yi Q, Roberts RS, Miller TD, Schaer GL, et al. The relationships of left ventricular ejection fraction, end-diastolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J Am Coll Cardiol. 2002;39:30–6. - PubMed
    1. Talukder MA, Kalyanasundaram A, Zuo L, Velayutham M, Nishijima Y, Periasamy M, et al. Is reduced SERCA2a expression detrimental or beneficial to postischemic cardiac function and injury? Evidence from heterozygous SERCA2a knockout mice. Am J Physiol Heart Circ Physiol. 2008;294:H1426–34. - PubMed
    1. Schultz JEJ, Glascock BJ, Witt SA, Nieman ML, Nattamai KJ, Liu LH, et al. Accelerated onset of heart failure in mice during pressure overload with chronically decreased SERCA2 calcium pump activity. Am J Physiol Heart Circ Physiol. 2004;286:H1146–53. - PubMed

Publication types

MeSH terms

Substances